Sidley Food, Drug and Medical Device partner Arif S. Noorani and M&A partner Ruchun Ji will speak on panels at the EBD Group's Asia Bio Partnering Forum.
Arif will speak on the “From Regulation to Realisation — Building Ecosystems for Emerging Therapeutics in APAC” panel. This panel will explore how biotech companies and regional stakeholders can align strategies to bring these therapies to market faster and more effectively. Panelists will also discuss overcoming regulatory fragmentation, addressing manufacturing bottlenecks, and the strategic value of cross-border and public-private partnerships.
Ruchun will moderate the “The Art of the Deal: NewCos and the Next Chapter of Biotech Strategy” panel. This panel explores the evolving art of the deal: what’s working, what’s next, and how pharma, VCs, and startups are collaborating to build the next generation of biotech success stories.
